3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
139
Breast Neoplasms
31
Prostatic Neoplasms
29
Insulin Resistance
28
Obesity
19
Pancreatic Neoplasms
13
Neoplasms
12
Infertility
12
Endometrial Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Colorectal Neoplasms
11
Anovulation
9
Lung Neoplasms
8
Metabolic Syndrome
7
Melanoma
7
Hyperandrogenism
7
Glioblastoma
7
Diabetes Mellitus
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Rectal Neoplasms
5
Adenocarcinoma
5
Weight Loss
4
Urinary Bladder Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma of Lung
4
Uterine Cervical Neoplasms
3
Recurrence
3
Interventions
Cyclophosphamide
64
fludarabine phosphate
37
Peripheral Blood Stem Cell Transplantation
30
Cyclosporine
30
Radiotherapy
28
Mycophenolic Acid
28
Filgrastim
28
Busulfan
28
Whole-Body Irradiation
26
Antilymphocyte Serum
24
Melphalan
19
Etoposide
19
Tacrolimus
16
Methotrexate
16
Cord Blood Stem Cell Transplantation
16
Methylprednisolone
15
Rituximab
14
Thiotepa
10
Cytarabine
10
Vincristine
8
Prednisone
8
Doxorubicin
8
Carboplatin
7
fludarabine
5
Sirolimus
5
sargramostim
4
glofitamab
4
aldesleukin
4
Therapeutics
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dendritic Cell Sarcoma, Interdigitating
×
Metformin
×
Clear all
NCT02531308
2022-09-28
DLBCL
Rush University Medical Center
Phase 2
Terminated
5 enrolled
5 charts